Department of Interventional Radiology, University of Miami Miller School of Medicine, Miami, FL.
University of Miami Miller School of Medicine, Miami, FL.
Tech Vasc Interv Radiol. 2020 Sep;23(3):100694. doi: 10.1016/j.tvir.2020.100694. Epub 2020 Oct 6.
Hematuria of prostatic origin has multiple etiologies including benign prostatic hyperplasia (BPH), iatrogenic urological trauma, prostate cancer, and radiation therapy. Hematuria secondary to benign prostatic hyperplasia can occur because of the increased vascularity of the primary gland, itself, or because of the vascular re-growth following a transurethral resection of the prostate. Prostatic hematuria usually resolves with conservative measures; however, refractory hematuria of prostatic origin may require hospitalization with treatment with blood transfusions, repeated indwelling urinary catheterization, and continuous bladder irrigation. Prostate artery embolization is an emerging minimally invasive procedural therapy for men with BPH that was originally utilized for the treatment of refractory hematuria of prostatic origin . This article aims to summarize the currently available evidence around prostate artery embolization for the treatment of refractory hematuria of prostatic origin.
前列腺源性血尿有多种病因，包括良性前列腺增生（BPH）、医源性尿路创伤、前列腺癌和放射治疗。良性前列腺增生引起的血尿可能是由于原发腺体本身的血管增多，也可能是由于经尿道前列腺切除术（TURP）后的血管再生。前列腺血尿通常可以通过保守治疗解决；然而，前列腺源性难治性血尿可能需要住院治疗，包括输血、反复留置导尿和持续膀胱冲洗。前列腺动脉栓塞术是一种新兴的微创治疗前列腺增生的方法，最初用于治疗前列腺源性难治性血尿。本文旨在总结目前关于前列腺动脉栓塞术治疗前列腺源性难治性血尿的可用证据。
